Medication info
Double Star Tablet 40/5 mg

Double Star Tablet 40/5 mg

Prescription medicationOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
TDS Pharm Co., Ltd.
Appearance
A double convex oval-shaped tablet that is white and light blue.
Packaging
30 tablets (10 tablets/PTP × 3), 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201900626 · Approved 2019.01.24 · Insurance code 679801750

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time every day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 mg. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients who should use this medicine with caution’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
TDS Pharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used for the treatment of essential hypertension in patients whose blood pressure is not adequately controlled with monotherapy from telmisartan or amlodipine. It effectively lowers blood pressure and helps reduce cardiovascular risk.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time every day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 mg. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients who should use this medicine with caution’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus if used during pregnancy, particularly in the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. This medication should not be administered to patients with certain conditions, such as severe liver disease, heart valve problems, severe hypotension, or patients in an unstable condition post-acute myocardial infarction. Special caution is required for patients with primary aldosteronism, impaired liver function, gastrointestinal disorders, or issues with renal vasculature. Common side effects during treatment include dizziness and peripheral edema, and serious side effects may rarely occur; therefore, immediate consultation with healthcare providers is necessary if symptoms appear. It is vital not to use this medication during pregnancy, and if pregnancy is confirmed, it should be discontinued as soon as possible. Due to the risk of excessively low blood pressure, special care must be taken if fluids or salt are insufficient, and proper treatment should be sought immediately if signs of hypotension occur. Regular blood tests to monitor potassium levels are recommended, as this medication may increase serum potassium. Patients with renal problems should frequently check their kidney function before and during treatment, and caution is needed as there is limited experience using this medication in kidney transplant patients. During treatment, patients may experience dizziness or drowsiness when driving or operating dangerous machinery. There is potential for drug interactions, so any current medications should be disclosed to healthcare providers, particularly when taken alongside specific heart medications, diuretics, and analgesics. In case of overdose, symptoms such as low blood pressure, dizziness, and heart rhythm abnormalities may occur; immediate emergency treatment is necessary, and self-treatment should be avoided. This medication is not recommended for children due to the establishment of safety and efficacy being lacking. For the elderly, reactions to the medication may be more sensitive, so careful dose adjustment is recommended.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 111 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • sensory loss
  • dysgeusia
  • tremor
  • extrapyramidal disorder
  • hypertonia
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flush
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver disease
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • frequent urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • interstitial lung disease
  • interstitial pneumonia
  • eosinophilic pneumonia
  • hepatocellular carcinoma
  • cerebral infarction
  • congestive heart failure
  • musculoskeletal pain
  • neck pain
  • nasopharyngitis
  • upper abdominal discomfort
  • upper abdominal pain
  • position-related dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that blocks light, at a temperature between 1°C and 30°C. Proper storage will help maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

A double convex oval-shaped tablet that is white and light blue.

Package unit

30 tablets (10 tablets/PTP × 3), 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.